ÂÜÀòÂÒÂ×

Dr. Evripidis (Evris) Gavathiotis is a Professor of Biochemistry and Medicine at Albert Einstein College of Medicine and a Co-Leader of the Cancer Therapeutics Program at Albert Einstein Cancer Center. His research focuses on mechanisms and protein interactions in cell death and cell survival pathways in cancer and the discovery and optimization of small molecule modulators towards novel chemical tools and therapeutics.

Dr. Gavathiotis has pioneered mechanistic insights of BCL-2 family proteins and other key signaling proteins and has developed strategies based on computational and biophysical methodologies that enabled the discovery of first-in-class small molecules for several challenging targets. He has been honored with several prestigious awards including the Sidney Kimmel Scholar Award for Cancer Research, the Pershing Square Sohn Prize in Cancer Research and the Young Chemical Biologist Award by the International Chemical Biology Society.

Dr. Gavathiotis has co-authored numerous high impact publications, more than 30 United States patent applications and he is a co-founder of three biotechnology companies. He has a PhD in Biological Chemistry from the University of Nottingham and received postdoctoral training at Rockefeller University and Dana Farber Cancer Institute-Harvard Medical School.